These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12060122)

  • 41. Nomogram predictive models for adult patients with acute lymphoblastic leukaemia based on real-world treatment outcomes.
    Chen Y; Chen Y; Wu Z; Li J; Huang Y; Peng X; Zheng J; Wu Y; Hu J
    Ann Hematol; 2024 Jul; 103(7):2393-2404. PubMed ID: 38480542
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial.
    Ribera JM; Oriol A; Morgades M; Montesinos P; Sarrà J; González-Campos J; Brunet S; Tormo M; Fernández-Abellán P; Guàrdia R; Bernal MT; Esteve J; Barba P; Moreno MJ; Bermúdez A; Cladera A; Escoda L; García-Boyero R; Del Potro E; Bergua J; Amigo ML; Grande C; Rabuñal MJ; Hernández-Rivas JM; Feliu E
    J Clin Oncol; 2014 May; 32(15):1595-604. PubMed ID: 24752047
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Imatinib in combination with allogeneic hematopoietic stem cell transplantation improved the outcome of adult Philadelphia chromosome-positive acute lymphoblastic leukemia].
    Cheng Z; Zhao L; Chen G; Wu D; Qiu H; Tang X; Fu C; Jin Z; Chen F; Xue S; Sun A
    Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):114-9. PubMed ID: 24606651
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term survival in acute lymphoblastic leukaemia in adults treated according to the LALA 87 protocol.
    Colović M; Bogdanović A; Janković G; Kraguljac N; Suvajdzić N
    Chemotherapy; 2003 Jun; 49(3):138-45. PubMed ID: 12815207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outcome after first relapse in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia.
    Kako S; Kanamori H; Kobayashi N; Shigematsu A; Nannya Y; Nakamae M; Shigeno K; Suzukawa K; Takeuchi M; Tsuzuki M; Usuki K; Hatanaka K; Ogawa K; Mitani K; Nawa Y; Hatta Y; Mizuno I; Kanda Y
    Br J Haematol; 2013 Apr; 161(1):95-103. PubMed ID: 23368421
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL).
    Ottmann OG; Wassmann B; Pfeifer H; Giagounidis A; Stelljes M; Dührsen U; Schmalzing M; Wunderle L; Binckebanck A; Hoelzer D;
    Cancer; 2007 May; 109(10):2068-76. PubMed ID: 17429836
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia.
    Thomas X; Archimbaud E; Charrin C; Magaud JP; Fiere D
    Leukemia; 1995 Feb; 9(2):249-53. PubMed ID: 7532767
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Poor outcome of intensive chemotherapy for adult acute lymphoblastic leukemia: a possible dose effect.
    Chiu EK; Chan LC; Liang R; Lie A; Kwong YL; Todd D; Chan TK
    Leukemia; 1994 Sep; 8(9):1469-73. PubMed ID: 8090027
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Successful treatment with imatinib combined with less intensive chemotherapy (vincristine and dexamethasone) as induction therapy in a very elderly patient with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Nishii K; Sakakura M; Tsukada T; Ryuu H; Katayama N
    Int J Hematol; 2007 Apr; 85(3):273-4. PubMed ID: 17483068
    [No Abstract]   [Full Text] [Related]  

  • 50. [Long-term destiny of adolescents and young adults with de novo acute lymphoblastic leukemia treated with a pediatric protocol type].
    López-Hernández MA; Alvarado-Ibarra M; Álvarez-Veral JL; Ortiz-Zepeda M; Guajardo-Leal ML; Cota-Range X
    Gac Med Mex; 2016; 152(5):439-443. PubMed ID: 27792701
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Myeloid markers in adult acute lymphocytic leukemia. Correlations with patient and disease characteristics and with prognosis.
    Preti HA; Huh YO; O'Brien SM; Andreeff M; Pierce ST; Keating M; Kantarjian HM
    Cancer; 1995 Nov; 76(9):1564-70. PubMed ID: 8635059
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcome of treatment of adult acute lymphoblastic leukemia with hyperfractionated cyclophosphamide, doxorubicin, vincristine, dexamethasone/methotrexate, cytarabine: results from an Australian population.
    Morris K; Weston H; Mollee P; Marlton P; Gill D; Kennedy G
    Leuk Lymphoma; 2011 Jan; 52(1):85-91. PubMed ID: 21133717
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Description and prognostic significance of the kinetics of minimal residual disease status in adults with acute lymphoblastic leukemia treated with HyperCVAD.
    Cassaday RD; Stevenson PA; Wood BL; Becker PS; Hendrie PC; Sandmaier BM; Radich JL; Shustov AR
    Am J Hematol; 2018 Aug; 93(4):546-552. PubMed ID: 29318644
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The prospects for children with acute lymphoblastic leukemia of being cured has increased in the Czech Republic in the 21st century to 90% - outcome of the ALL-IC BFM 2002 trial].
    Zdráhalová K; Štěrba J; Domanský J; Blažek B; Ptoszková H; Mihál V; Novák Z; Hak J; Procházková D; Černá Z; Timr P; Jabali Y; Sedláček P; Smíšek P; Zemanová Z; Jarošová M; Houdková A; Mejstříková E; Hrušák O; Zuna J; Janotová I; Trka J; Starý J
    Cas Lek Cesk; 2015; 154(2):79-89. PubMed ID: 25994910
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
    Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
    Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Successful treatment of a pregnant woman with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Nakajima Y; Kuwabara H; Hattori Y; Ohshima R; Sakai R; Kitagawa M; Tomita N; Ishigatsubo Y; Fujisawa S
    Int J Hematol; 2013 Mar; 97(3):427-9. PubMed ID: 23359302
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukaemia.
    Rohatiner AZ; Bassan R; Battista R; Barnett MJ; Gregory W; Lim J; Amess J; Oza A; Barbui T; Horton M
    Br J Cancer; 1990 Sep; 62(3):454-8. PubMed ID: 2206954
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Analysis of Clinical Characteristics and Therapeutic Efficacy in 61 Adult Patients with Acute Lymphoblastic Leukemia].
    Zhang XP; Chen BA; Ge Z; Liu R; Ma XY; Gao C
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):711-717. PubMed ID: 28641623
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Experience with vincristine, doxorubicin, and dexamethasone (VAD) chemotherapy in adults with refractory acute lymphocytic leukemia.
    Kantarjian HM; Walters RS; Keating MJ; Barlogie B; McCredie KB; Freireich EJ
    Cancer; 1989 Jul; 64(1):16-22. PubMed ID: 2659160
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial.
    Conter V; Valsecchi MG; Silvestri D; Campbell M; Dibar E; Magyarosy E; Gadner H; Stary J; Benoit Y; Zimmermann M; Reiter A; Riehm H; Masera G; Schrappe M
    Lancet; 2007 Jan; 369(9556):123-31. PubMed ID: 17223475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.